{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-039263","form_type":"8-K","ticker":"PSA","cik":"0001393311","company_name":"Public Storage","filed_at":"2026-06-01T10:01:44+00:00","discovered_at":"2026-06-01T10:10:00.263487+00:00","generated_at":"2026-06-01T10:10:32.906498+00:00","sec_items":["7.01","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Public Storage reports operating update: same-store occupancy 92.2%, churn improves to 16.4%","bullets":["Same-store portfolio of 2,755 facilities (192.1M sq ft): occupancy 92.2% vs 92.1% YoY.","Move-in average annual rent $13.10/sq ft (-0.2% YoY); move-out rent $18.98/sq ft (-4.1% YoY).","Same-store churn improved to 16.4% from 19.6% YoY, a 3.2 percentage point decline.","Data covers April 1 – May 28, 2026 vs 2025; presented at investor conference."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039263","json":"https://secwatch.observer/filing/0001628280-26-039263.json","markdown":"https://secwatch.observer/filing/0001628280-26-039263.md","text":"https://secwatch.observer/filing/0001628280-26-039263.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1393311/000162828026039263/0001628280-26-039263-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1393311/000162828026039263/psa-20260601.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T10:10:32.906498+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001171843-26-003840","ticker":"EDAP","company_name":"EDAP TMS SA","filed_at":"2026-06-01T20:05:28+00:00","headline":"EDAP TMS holds FocalTherics Investor Day; plans to exit ESWL and distribution segments to focus on HIFU","event_type":"other_material","sec_items":["7.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same SEC item: 7.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-003840","json":"https://secwatch.observer/filing/0001171843-26-003840.json","markdown":"https://secwatch.observer/filing/0001171843-26-003840.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1041934/000117184326003840/0001171843-26-003840-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1041934/000117184326003840/f8k_060126.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-251382","ticker":"MANH","company_name":"MANHATTAN ASSOCIATES INC","filed_at":"2026-06-01T20:03:46+00:00","headline":"Manhattan Associates to cut ~6% of global headcount; expects $7M-$9M in severance costs in Q2 2026","event_type":"other_material","sec_items":["2.05","7.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 7.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251382","json":"https://secwatch.observer/filing/0001193125-26-251382.json","markdown":"https://secwatch.observer/filing/0001193125-26-251382.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1056696/000119312526251382/0001193125-26-251382-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1056696/000119312526251382/manh-20260601.htm"},"side_by_side_evidence":null},{"accession":"0001636282-26-000075","ticker":"SYRE","company_name":"Spyre Therapeutics, Inc.","filed_at":"2026-06-01T20:01:39+00:00","headline":"Spyre Therapeutics expands SPY003 license field beyond IBD with dosing restrictions until 2028-2030","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same SEC item: 8.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001636282-26-000075","json":"https://secwatch.observer/filing/0001636282-26-000075.json","markdown":"https://secwatch.observer/filing/0001636282-26-000075.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1636282/000163628226000075/0001636282-26-000075-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1636282/000163628226000075/syre-20260529.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-063481","ticker":"ORKA","company_name":"Oruka Therapeutics, Inc.","filed_at":"2026-06-01T20:01:27+00:00","headline":"Oruka Therapeutics expands ORKA-001 license to include IBD; clinical dosing restrictions until 2028-2030","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same SEC item: 8.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-063481","json":"https://secwatch.observer/filing/0001213900-26-063481.json","markdown":"https://secwatch.observer/filing/0001213900-26-063481.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/907654/000121390026063481/0001213900-26-063481-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/907654/000121390026063481/ea0292876-8k_oruka.htm"},"side_by_side_evidence":null},{"accession":"0001606268-26-000032","ticker":"VIASP","company_name":"Via Renewables, Inc.","filed_at":"2026-06-01T19:06:57+00:00","headline":"Via Renewables to redeem all 1,884,935 shares of its 8.75% Series A Preferred at $25.00 per share plus dividends","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same SEC item: 8.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001606268-26-000032","json":"https://secwatch.observer/filing/0001606268-26-000032.json","markdown":"https://secwatch.observer/filing/0001606268-26-000032.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1606268/000160626826000032/0001606268-26-000032-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1606268/000160626826000032/spke-20260601.htm"},"side_by_side_evidence":null},{"accession":"0001437749-26-018969","ticker":"TRLC","company_name":"TriLinc Global Impact Fund LLC","filed_at":"2026-06-01T16:43:41+00:00","headline":"TriLinc Global Impact Fund portfolio assets ~$283M as of April 30, 2026","event_type":"other_material","sec_items":["8.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same SEC item: 8.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-018969","json":"https://secwatch.observer/filing/0001437749-26-018969.json","markdown":"https://secwatch.observer/filing/0001437749-26-018969.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1550453/000143774926018969/0001437749-26-018969-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1550453/000143774926018969/trlc20260513_8k.htm"},"side_by_side_evidence":null},{"accession":"0000015847-26-000009","ticker":"BUKS","company_name":"BUTLER NATIONAL CORP","filed_at":"2026-06-01T16:41:32+00:00","headline":"CEO Christopher Reedy discloses ongoing cancer treatment; remains in role","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same SEC item: 8.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000015847-26-000009","json":"https://secwatch.observer/filing/0000015847-26-000009.json","markdown":"https://secwatch.observer/filing/0000015847-26-000009.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/15847/000001584726000009/0000015847-26-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/15847/000001584726000009/buks-20260601.htm"},"side_by_side_evidence":null},{"accession":"0001437749-26-018930","ticker":"CPSH","company_name":"CPS TECHNOLOGIES CORP/DE/","filed_at":"2026-06-01T13:35:50+00:00","headline":"CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share","event_type":"other_material","sec_items":["1.01","5.03","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same SEC item: 8.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-018930","json":"https://secwatch.observer/filing/0001437749-26-018930.json","markdown":"https://secwatch.observer/filing/0001437749-26-018930.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/0001437749-26-018930-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/cpsh20260528_8k.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}